Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors
Clinical trial NCT05089266 · UNKNOWN
Trial details
- NCT number
- NCT05089266
- Sponsor
- Shanghai Cell Therapy Group Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2024-07-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.